Related Experiment Video
Updated: May 22, 2026
09:03
Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies
Published on: June 30, 2023
Effects of aging on angiogenesis
Johanna Lähteenvuo1, Anthony Rosenzweig
1Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Circulation Research
|April 28, 2012
Summary
Aging impairs blood vessel formation (angiogenesis) and function, increasing cardiovascular disease risk in older adults. This review explores age-related molecular changes and therapeutic strategies to improve vascular health in the elderly.
Area of Science:
- Cardiovascular Science
- Aging Research
- Vascular Biology
Background:
- Aging is a primary risk factor for cardiovascular diseases.
- Impaired angiogenesis and endothelial dysfunction are prevalent in the elderly, exacerbating cardiovascular conditions.
- Understanding these age-related vascular changes is crucial for managing cardiovascular disease.
Purpose of the Study:
- To review the molecular mechanisms underlying impaired angiogenesis in aging.
- To discuss potential therapeutic strategies for enhancing vascular function in elderly patients.
- To highlight the implications for cardiovascular disease management in aging populations.
Main Methods:
- Literature review of molecular mechanisms of aging and angiogenesis.
- Analysis of studies on endothelial function in the elderly.
- Synthesis of current therapeutic approaches for vascular repair.
Main Results:
- Aging is associated with molecular alterations that impair angiogenesis.
- Endothelial dysfunction is a key feature of aging vasculature.
- Therapeutic induction of angiogenesis shows promise for treating ischemic diseases.
Conclusions:
- Age-related impairment of angiogenesis and endothelial function significantly impacts cardiovascular health.
- Targeting molecular pathways involved in angiogenesis may offer therapeutic benefits for aging patients.
- Further research into these mechanisms can lead to improved cardiovascular disease management in the elderly.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:19The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...